Free Trial

CONMED (CNMD) Earnings Date, Estimates & Call Transcripts

CONMED logo
$37.35 +0.71 (+1.93%)
Closing price 03:59 PM Eastern
Extended Trading
$37.32 -0.03 (-0.07%)
As of 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CONMED Earnings Summary

CONMED released Q1 2026 earnings on April 29, 2026, reporting an EPS of $0.89, which topped the consensus estimate of $0.82 by $0.07. Quarterly revenue fell 1.3% year-over-year to $317.05 million, above the consensus estimate of $310.64 million. With a trailing EPS of $1.77 and a P/E Ratio of 21.10, CONMED's earnings are expected to grow 11.19% next year, from $4.38 to $4.87 per share.

Latest Q1
Earnings Date
Apr. 29Estimated
Consensus EPS
(Apr. 29)
$0.82
Actual EPS
(Apr. 29)
$0.89 Beat By $0.07
Actual Revenue
(Apr. 29)
$317.05M

Q1 2026 Earnings Resources

Get CONMED Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CONMED and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CNMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CNMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CONMED Analyst EPS Estimates

Current Year EPS Consensus Estimate
$4.38 EPS
Next Year EPS Consensus Estimate
$4.87 EPS

CONMED Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/29/2026Q1 2026$0.82$0.89+$0.07$0.45$310.64M$317.05M
1/28/2026Q4 2025$1.32$1.43+$0.11$0.54$366.88M$373.20M
11/5/2025Q3 2025$1.05$1.08+$0.03$0.09$334.76M$337.93M
7/30/2025Q2 2025$1.13$1.15+$0.02$0.69$338.42M$342.35M
4/30/2025Q1 2025$0.81$0.95+$0.14$0.19$313.38M$321.26M
2/5/2025Q4 2024$1.20$1.34+$0.14$1.08$341.05M$345.94M
10/30/2024Q3 2024$0.99$1.05+$0.06$0.53$318.46M$316.70M
7/31/2024Q2 2024$0.92$0.98+$0.06$1.00$334.39M$332.10M

Data powered by Fiscal.ai.

CONMED Earnings - Frequently Asked Questions

CONMED (NYSE:CNMD) last announced its quarterly earning data on Wednesday, April 29, 2026. Learn more on CNMD's earnings history.

CONMED updated its FY 2026 earnings guidance on Wednesday, April, 29th. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

In the previous quarter, CONMED (NYSE:CNMD) reported $0.89 earnings per share (EPS) to beat the analysts' consensus estimate of $0.82 by $0.07. Learn more on analysts' earnings estimate vs. CNMD's actual earnings.

The conference call for CONMED's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for CONMED's latest earnings report can be read online.
Read Transcript

CONMED's earnings report can be found in their filing with the SEC.
View SEC filing

CONMED (NYSE:CNMD) has a recorded annual revenue of $1.37 billion.

CONMED (NYSE:CNMD) has a recorded net income of $47.06 million. CNMD has generated $1.77 earnings per share over the last four quarters.

CONMED (NYSE:CNMD) has a trailing price-to-earnings ratio of 21.10 and a forward price-to-earnings ratio of 8.55. The price/earnings-to-growth ratio is 1.61.

CONMED's earnings are expected to grow from $4.37 per share to $4.87 per share in the next year, which is a 11.44% increase.


This page (NYSE:CNMD) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners